Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

Initiating Coverage on Sudarshan Chemical - Leaping into the league of giants - HDFC Securities

Posted On: 2020-11-20 04:11:34 (Time Zone: Arizona, USA)


Mr. Nilesh Ghuge & Mr. Harshad Katkar, Head Institutional, HDFC Securities

For the period over August-16 to November-20, the stock of Sudarshan Chemical Industries Ltd (SCIL) was merely up by 10%, despite EBITDA expanding at a 10% CAGR, and PAT doubling at a 19% CAGR. This is after considering the 48% stock rally from its March-20 lows until November. SCIL plans to become the third-largest pigment manufacturer globally by developing R&D capabilities, operational efficacy, and expanding to new geographies. Global scale is the key to success in the pigment business.

Two major global players shifting away from the pigment business could act as a tailwind for Indian pigment manufacturers. We believe SCIL is in a sweet spot to seize this opportunity by offering products similar to those of global players. We initiate coverage on the stock with a BUY recommendation. Our DCF-based target price of INR 550/sh (WACC of 10% and terminal growth rate of 3%) implies an upside of 21.5% from the current level (implied PE of 24x).

On the path to becoming the third-largest pigment manufacturer globally: In India, SCIL is the largest pigment manufacturer (with >35% market share) while globally, it is the fourth-largest. We believe it is positioned well to achieve the top-3 status by focusing on its core business, developing R&D, expanding to new markets, and improving manufacturing and operations. We also believe that having this global scale is essential to success in pigments as it leads to sustainable growth, cheaper feedstock, and access to cutting-edge technologies.

Capex to focus on high-value products and new product launches: SCIL's current Capex cycle was started in FY17. It has incurred INR 5.5bn over FY17-20 and planned for INR 3.5bn over FY21-FY22E. While a significant portion of Capex targets growth, some part of it is targeting margin expansion. We expect asset-turnover to be ~2.3-2.5x at peak utilisation.

Further, SCIL is enhancing its product mix towards higher-margin and higher-realisation speciality products such as azo pigments, cosmetics and pigment dispersions vs. non-speciality ones. It plans to launch ~25 products globally.

Earnings to grow at a 20% CAGR, and return ratios to improve over FY21-24E: We expect revenue to grow at a 14.8% CAGR over FY21-24E given SCIL's plans for geographical expansion and new product offerings, while, APAT CAGR would be ahead of revenue growth at 20%. SCIL will generate OCF/FCF yield of 7.5/4.2% in FY24E. RoE and RoIC to expand from 19.0/11.5% in FY21E to 23.9/15.3% in FY24E. Valuations are contextually moderate at 22.8/17.9x FY22/23E EPS.

Shares of SUDARSHAN CHEMICAL INDUSTRIES LTD. was last trading in BSE at Rs.450.25 as compared to the previous close of Rs. 453.1. The total number of shares traded during the day was 4268 in over 362 trades.

The stock hit an intraday high of Rs. 459.75 and intraday low of 450.25. The net turnover during the day was Rs. 1941388.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Easy Trip Planners Ltd. - IPO - Strong Financials - Reliance Securities

Bharat Forge - Initiating Coverage - Constant evolution - HDFC Securities

Mahindra Logistics - Large-ticket deal win - ICICI Securities

Company Update - Huhtamaki India - ICICI Direct

Gladiator Stocks: IndusInd Bank, VIP Industries - ICICI Direct

Warehousing demand expected to grow around 160% to reach 35 million sq. ft in 2021: JLL

Telecom - Spectrum auction: Prudent investment by Bharti Airtel - ICICI Securities

JB Chemicals & Pharmaceuticals - Analyst meet takeaways - ICICI Securities

IPO Review - MTAR Technologies Ltd - ICICI Direct

Auto Sector - Monthly Volume Round-up - Feb 21 - Decent YoY Growth Continues

Aditya Birla Fashion and Retail - Focus on scaling up new businesses - ICICI Securities

Automobiles (wholesale) - Wholesales push continues despite modest retail trends - ICICI Securities

Aditya Birla Capital - Thoughtful (inclusive) conglomerate business evolution commands premium - ICICI Securities

Jubilant Foodworks - Buying in-the-money options - ICICI Securities

Multi Commodity Exchange of India - Play on rising commodity prices? - ICICI Securities

Gladiator Stocks - Sudarshan Chemical - ICICI Direct

Monthly Commodities Outlook - March 2021 - ICICI Direct

ICICI Direct - Monthly Currency Outlook: Rupee to depreciate further towards 75.00 level...

ICICI Direct - Covid Recovery Pulse - E-way bill generation in February 2021 starts on strong note...

Company Update - Virtual JLR Investor Event - Tata Motors - ICICI Direct

Analyst Meet Update - Aditya Birla Fashion and Retail - ICICI Direct

MTAR Technologies Ltd. - IPO - Huge Opportunities from Clean Energy Bodes Well - Reliance Research

ICICI Direct Derivatives Weekly View (February 26): Failure to move above 14700 may extend declines towards 14300...

Bank: Sector Credit Trends - Slows, Yet again - HDFC Securities

Piramal Enterprises - Pharma day highlights - ICICI Securities

Polymer price tracker - PVC prices rise sharply again! - ICICI Securities

Greenply Industries - Growth returns, at an inflection point - ICICI Securities

Tata Motors - JLR future proofing itself with rapid electric transition - ICICI Securities

Dairy - Higher freight cost and increase in Global SMP prices - ICICI Securities

Analyst Meet Update - Nestlé India (Hold): Focus on product innovation, expanding rural reach - ICICI Direct

MTAR Technologies Ltd - A strong player in booming high precision engineering... - Geojit

Rollover Report for February - March 2021 : Angel Broking

Reaction from industry experts on Q3FY21 GDP numbers

M. Govinda Rao, Chief Economic Adviser, Brickwork ratings on Q3FY21 GDP numbers

Mr. Dhiraj Relli, MD & CEO, HDFC securities views on Q3FY21 GDP Growth Number

Suman Chowdhury, Chief Analytical Officer, Acuité Ratings & Research on Q3FY21 GDP

Rollover Analysis - Feb 21, 2021 - YES Securities

Consumer Durables - Demand-driven recovery continues - HDFC Securities

Cement - Demand surprises; earnings upgrade to continue - ICICI Securities

Gladiator Stocks - TeamLease Services - ICICI Direct

Gladiator Stocks - Metals to outshine post multi-year breakout... - ICICI Direct

Company Update - Sundaram Finance - ICICI Direct

Indian pharmaceutical industry to meet an ambition of US$130 billion by 2030 through innovation-led growth: EY-FICCI report

4th Industrial Conclave - Bullish undertone, favourable valuation - HDFC Securities

Sanofi India - Weak quarter; sequential improvement - ICICI Securities

Sunteck Realty - All eyes on upcoming launches - ICICI Securities

Company Update - Tata Motors - ICICI Direct

Q4CY20 Company Update - Mahindra CIE Automotive - ICICI Direct

Event Update - Hindalco - ICICI Direct

EY report launch at BioAsia 2021 - Moving the needle: Healthcare industry in a post-COVID world



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2020